A simplified score to quantify comorbidity in COPD.

Area of Science:

• Pulmonary Medicine
• Clinical Epidemiology
• Health Outcomes Research

Background:

• Comorbidities are prevalent in Chronic Obstructive Pulmonary Disease (COPD), but their impact on patient-centered outcomes is challenging to quantify.
• Existing COPD-specific indices predict mortality or general quality of life, but not specific patient-centered outcomes.

Purpose of the Study:

• To develop and validate a COPD-specific comorbidity score that accurately reflects the burden of comorbidities on patient-centered outcomes.
• To assess the predictive performance of different comorbidity scoring methods.

Main Methods:

• Developed and compared three comorbidity scoring techniques (simple count, weighted score, statistically selected weighted score) using the COPDGene study cohort (GOLD II-IV COPD).
• Validated scores internally by assessing associations with St. George's Respiratory Questionnaire (SGRQ), six-minute walk distance (6MWD), modified Medical Research Council (mMRC) dyspnea score, and exacerbation risk.
• Externally validated the chosen score in the SPIROMICS cohort.

Main Results:

• All developed comorbidity scores demonstrated comparable associations with patient-centered outcomes and added significant predictive ability to existing models.
• The simple comorbidity count showed strong performance in external validation for predicting SGRQ, mMRC, 6MWD, and exacerbation risk (AUCs ranging from 0.7086 to 0.7891).

Conclusions:

• Quantifying comorbidity burden provides a more comprehensive understanding of patient-centered outcome risks in COPD.
• A simple comorbidity count is a well-performing and practical tool for assessing comorbidity burden in diverse COPD populations.